secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001628280-23-027839
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q2 revenue falls 34.7% to $296.2M; diluted EPS $2.77 vs $3.42
----------------------------------------------------------------------

- Revenue $296.2M (-34.7%); net income $30.3M, EPS $2.77 vs $39.1M, $3.42 prior.
- Active earning OPTA VIA coaches down 21.9% to 53,100; revenue per coach $5,578.
- Q3 2023 guidance: revenue $220-$240M, diluted EPS $0.71-$1.32, tax rate 23-25%.
- Cash $147.4M, no debt; quarterly dividend of $1.65 per share declared.
- CEO cites economic headwinds, cost initiatives; new OPTA VIA ACTIVE line launched.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/med-20230807.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-027839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer